< 生产厂家价格 >

4-叔丁基环己烷甲酸

4-叔丁基环己烷甲酸名称

[ CAS 号 ]:
5451-55-8

[ 中文名 ]:
4-叔丁基环己基甲酸

[ 英文名 ]:
4-tert-Butylcyclohexanecarboxylic acid

[中文别名 ]:

4-叔丁基环己甲酸

[英文别名 ]:

4-tert-butylcyclohexane-1-carboxylic acid
4-tert-butylcyclohexane carboxylic acid
4-(2-Methyl-2-propanyl)cyclohexanecarboxylic acid
4-tert-Butylcyclohexanecarboxylic acid
Cyclohexanecarboxylic acid, 4-(1,1-dimethylethyl)-
MFCD00042622

4-叔丁基环己烷甲酸物理化学性质

[ 密度 ]:
1.0±0.1 g/cm3

[ 沸点 ]:
282.9±8.0 °C at 760 mmHg

[ 熔点 ]:
5451-55-8ºC

[ 分子式 ]:
C₁₁H₂₀O₂

[ 分子量 ]:
184.275

[ 闪点 ]:
136.7±13.1 °C

[ 精确质量 ]:
184.146332

[ PSA ]:
37.30000

[ LogP ]:
3.49

[ 蒸汽压 ]:
0.0±1.2 mmHg at 25°C

[ 折射率 ]:
1.474

[ 储存条件 ]:
室温，干燥

4-叔丁基环己烷甲酸MSDS

详细MSDS(安全技术说明书)

4-叔丁基环己烷甲酸安全信息

[ 个人防护装备 ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ 风险声明 (欧洲) ]:
R36/37/38

[ 安全声明 (欧洲) ]:
26-36/37/39

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
3

[ 海关编码 ]:
2916209090

4-叔丁基环己烷甲酸上下游产品

4-叔丁基环己烷甲酸上游产品

4-叔丁基环己烷甲酸下游产品

4-叔丁基环己烷甲酸海关

[ 海关编码 ]: 2916209090

[ 中文概述 ]:
2916209090 其他（环烷、环烯、环萜烯）一元羧酸（包括酸酐、酰卤化物，过氧化物和过氧酸及该税号的衍生物）. 增值税率:17.0% 退税率:9.0% 监管条件:AB(入境货物通关单,出境货物通关单) 最惠国关税:6.5% 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 丙烯酸、丙烯酸盐或酯应报明包装

[ 监管条件 ]: A.入境货物通关单 B.出境货物通关单

[ 检验检疫 ]: R.进口食品卫生监督检验 S.出口食品卫生监督检验 M.进口商品检验 N.出口商品检验

[ Summary ]:
2916209090 other cyclanic, cyclenic or cyclotherpenic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0%

4-叔丁基环己烷甲酸文献

Multicomponent NMR titration for simultaneous measurement of relative pKaS.

Anal. Chem. 68(13) , 2127-34, (1996)

An NMR titration method has been developed to simultaneously measure the difference in acid dissociation constants (delta pKa) of two or more compounds with high precision and accuracy. The delta pKa ...

Discovery of a novel CCR5 antagonist lead compound through fragment assembly.

Molecules 13(10) , 2426-41, (2008)

CCR5, as the major co-receptor for HIV-1 entry, is an attractive novel target for the pharmaceutical industry in the HIV-1 therapeutic area. In this study, based on the structures of maraviroc and 1,4...

Conformational analysis. LXXV. Methylation rates of cis-and trans-4-tert-butyl-N, N-dimethylcyclohexylamines. Allinger NL and Graham JC.

J. Org. Chem. 36(12) , 1688-90, (1971)

更多文献